Tg Therapeutics (TGTX) news
Recent news
TG Therapeutics rises 6.6%, most intraday since June 22
TG Therapeutics (TGTX) shares rose 6.6% in intraday trading on August 21, 2026, marking the largest single-day increase since June 22. The stock has gained approximately 70% year-to-date , driven by positive developments in its pipeline and investor optimism. Recent trading activity reflects strong…
AInvest Wire · Aug 21, 2026TG Therapeutics: on track to exit '26 at ~$1B US Briumvi revenue run rate
AInvest Wire · Aug 3, 2026Tg Therapeutics - raises FY 2026 total global revenue target to about $950 mln
AInvest Wire · Aug 3, 2026TG Therapeutics Q2 EPS USD 0.05
AInvest Wire · Aug 3, 2026TG Therapeutics Inc: JP Morgan raises target price to $65 from $46
On July 14, 2026, JPMorgan analyst Brian Cheng raised the price target for TG Therapeutics Inc. (NASDAQ:TGTX) to $65 from $46, while maintaining an Overweight rating on the stock. This update reflects the investment bank’s revised financial model following recent developments in clinical progress .…
AInvest Wire · Jul 14, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.